# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-21-137482
Filing Date
2021-04-29
Accepted
2021-04-28 19:36:29
Documents
7

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | d287319ddefa14a.htm | DEFA14A | 23762
2 | GRAPHIC | g287319txap1g1.jpg | GRAPHIC | 75764
3 | GRAPHIC | g287319txap2g1.jpg | GRAPHIC | 140650
4 | GRAPHIC | g287319txap3g1.jpg | GRAPHIC | 128288
5 | GRAPHIC | g287319txap4g1.jpg | GRAPHIC | 205411
6 | GRAPHIC | g287319txap5g1.jpg | GRAPHIC | 121238
7 | GRAPHIC | g287319txap6g1.jpg | GRAPHIC | 131740
| Complete submission text file | 0001193125-21-137482.txt |  | 1131748

Mailing Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120
Business Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120 33(0)155427878
DBV Technologies S.A. (Filer) CIK: 0001613780 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36697 | Film No.: 21866429
SIC: 2836 Biological Products, (No Diagnostic Substances)